National Jewish Health Health is conducting a research study looking at the safety and effectiveness of a study drug in combination with high doses of inhaled steroids and long acting bronchodilators for people with asthma who still have symptoms despite treatment with standard asthma drugs such as Advair.
- Be between the ages of 18-75
- Have a diagnosis of asthma
- Currently be using high doses of inhaled steroids and long acting bronchodilators for the treatment of asthma
This research study involves up to 17 visits over 1 year. Qualified participants will receive physical examinations, skin testing, lung function measurements, and study drug at no cost.In addition, Qualified participants will receive financial compensation for time and travel.